ms and semaglutide Tirzepatide Prescribing for Obesity SEMAGLUTIDE PEPTIDE VIAL – UMBRELLA

doi: 10.1016/j.molmet.2020.101102

it can be self-administered via injection in the abdomen or thighs

Liver health: NAFLD and NASH Non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), represent a growing health concern globally

The fundamental mechanism of action involves mimicking the physiological effects of endogenous GLP-1, which is secreted by intestinal L-cells in response to food intake

Contraindication: This product must not be used if skin lesions or open wounds are present. Warning: This product should not be used on individuals who have had skin cancer or have a family history of skin cancer. Warning: Persons repeatedly exposed to UV radiation should be regularly evaluated for skin cancer.